Skip to Content Skip to Content

Health Sciences

Reset All Filters
2004 Results
Penn Researchers Examine Effects of Federal Recommendations on Cartilage Repair Studies in Large Animal Models

Penn Researchers Examine Effects of Federal Recommendations on Cartilage Repair Studies in Large Animal Models

More than 21 million people in the United States suffer from cartilage damage, and if left untreated, cartilage defects can cause disability and more widespread joint disease. In recent years, scientists have focused on development of new treatments for cartilage repair. But in the past two decades there has been little to no adherence to the recommendations published by U.S.

Abbey Anderson

Family Risk of Breast Cancer Does Not Negatively Affect General Psychosocial Adjustment Among Pre-Teen Girls, Penn Study Finds

Family Risk of Breast Cancer Does Not Negatively Affect General Psychosocial Adjustment Among Pre-Teen Girls, Penn Study Finds

Girls from families with a history of breast cancer, or genetic mutations that increase the risk of a breast cancer diagnosis, seem to adjust just as well as other girls when it comes to general anxiety, depression and overall psychosocial adjustment, according to new research from the Perelman School of Medicine at the University of Pennsy

Katie Delach

National Academy of Medicine Elects Three New Members from Penn

National Academy of Medicine Elects Three New Members from Penn

Three professors from the University of Pennsylvania have been elected members to the National Academy of Medicine, one of the nation's highest honors in biomedicine. NAM was originally the Institute of Medicine, which was established in 1970 under the charter of the National Academy of Sciences to advise the nation on medical and health issues.

Karen Kreeger , Evan Lerner

Off-Kilter: Penn Study Identifies Differences in Treatment Effect on Out-of-Balance Microbiome in Crohn's Disease

Off-Kilter: Penn Study Identifies Differences in Treatment Effect on Out-of-Balance Microbiome in Crohn's Disease

Different treatments for Crohn's disease in children affects their gut microbes in distinct ways, which has implications for future development of microbial-targeted therapies for these patients, according to a study led by researchers from the Perelman School of Medicine at the University of Pennsylvania

Karen Kreeger

Penn Researchers: New Neuroimaging Method Better Identifies Epileptic Lesions

Penn Researchers: New Neuroimaging Method Better Identifies Epileptic Lesions

Epilepsy affects more than 65 million people worldwide. One-third of these patients have seizures that are not controlled by medications. In addition, one-third have brain lesions, the hallmark of the disease, which cannot be located by conventional imaging methods.

Lee-Ann Donnegan

NIH New Innovator Award Goes to Penn Bioengineer for Study of ‘3-D Epigenome’

NIH New Innovator Award Goes to Penn Bioengineer for Study of ‘3-D Epigenome’

The National Institutes of Health have named Jennifer Phillips-Cremins, an assistant professor in the University of Pennsylvania School of Engineering and Applied Science’s Department of Bioengineering, as a member of its

Evan Lerner

Penn Team Maps First Comprehensive Profile of Non-Protein-Coding RNAs to Provide Clinicians with New Way to Diagnose Array of Cancers

Penn Team Maps First Comprehensive Profile of Non-Protein-Coding RNAs to Provide Clinicians with New Way to Diagnose Array of Cancers

Growing insights about a significant, yet poorly understood, part of the genome – the “dark matter of DNA” -- have fundamentally changed the way scientists approach the study of diseases. The human genome contains about 20,000 protein-coding genes – less than 2 percent of the total – but 70 percent of the genome is made into non-coding RNA.

Karen Kreeger

Turncoat Protein Regulates Sensitivity of Breast Cancer Cells to Drug, Providing New Target for Preventing Relapses, Finds Penn Study

Turncoat Protein Regulates Sensitivity of Breast Cancer Cells to Drug, Providing New Target for Preventing Relapses, Finds Penn Study

A surprising, paradoxical relationship between a tumor suppressor molecule and an oncogene may be the key to explaining and working around how breast cancer tumor cells become desensitized to a common cancer drug, found researchers at the Perelman School of Medicine at the University of Pennsylvania

Karen Kreeger